Marine Drugs and Nanomedicine
A special issue of Marine Drugs (ISSN 1660-3397).
Deadline for manuscript submissions: closed (31 October 2018) | Viewed by 16679
Special Issue Editor
Interests: drug delivery; nanomedicine; liposomes; skin therapy; vaginal therapy
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Bioactive compounds of marine origin bear unexplored potentials in drug development. Some of them are already available as drugs, whereas many are promising and are approaching later stages of clinical trials. However, the means of delivery for these promising compounds remain unexploited to their full potential. Nanotechnology and nanomedicine could offer innovative approaches in the delivery of marine-origin drugs and active compounds. Nano-size carriers, often referred to as nanosystems, are expected to improve drug/compound bioavailabilities, achieve targeting to a desired site of action, with increased efficacy and reduced side effects. Moreover, marine-origin compounds can also serve as nanosystem building blocks. This Special Issue, “Marine Drugs and Nanomedicine” aims to provide an overview of the current research pipelines in nanosystems employed to deliver marine compounds via different routes of administration, or promising applications of marine raw materials as nanocarriers. Innovative approaches and systems able to assure controlled and targeted delivery are the focus of this Special Issue. As Guest Editor, I cordially invite contributions in form of original research articles or reviews from this exciting research field.
Prof. Dr. Natasa Skalko-Basnet
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Nanomedicine
- nanotechnology
- marine drugs
- nanocarriers
- controlled drug delivery
- drug targeting
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.
